RESPeRATE is the first and only medical device indicated for the adjunctive treatment of hypertension and the reduction of stress by the regulatory authorities in the US, Europe, Australia, Canada and major Asian countries. RESPeRATE can be combined with standard antihypertensive drugs and/or non-pharmacologic interventions.